Abbott (NYSE: ABT) has received CE Mark approval for its Amulet 360 Left Atrial Appendage (LAA) Occluder, a device designed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE